proteins), often termed "boronolectin", and considered a remarkably stable alternative to lectins with chemically tailored binding specificity. 3, 4 Lorand and Edwards were the first to quantitatively reveal this fascinating property of PBA back in 1959, which provoked a tremendous deal of research interest. 1 Since the late 1960s, PBA compounds have been extensively studied as a ligand for affinity chromatography for the separation of polyol compounds such as ribonucleic acid (RNA). [5] [6] [7] [8] [9] Optical and electrical chemosensing applications, including those focusing on glucose detection, were the next achievement. [10] [11] [12] The first concept of which appeared in the late 1990s and developments in this field are still active today. [13] [14] [15] [16] [17] Later works revealed that PBA could also interact with a variety of biological membranes including cells, viruses , bacteria and fungi through the membrane-constituting carbohydrate moieties. [18] [19] [20] [21] [22] For example, some poly(acrylamide) derivatives bearing PBA functionality can specifically bind to glycoprotein of lymphocytes and induces enhanced proliferation, a feature truly mimicking that of lectins. 23 Recent reports have shown that these interactions can provide a basis for (PBA-based) synthetic ligand to cells. 24, 25 Some others have exploited these interactions as a mode to trigger physicochemical changes of materials, a property useful for drug delivery applications. 26 In this mini-review, we discuss some new aspects of PBA-based diagnostic and therapeutic applications. Most of the works described here are from our own research efforts unless otherwise stated. First, we describe approaches of PBA-mediated targeting to sialic acid (SA), an anionic monosaccharide that frequently occurs at the termini of the glycan chains, as techniques relevant to tumor diagnosis and treatment. In the other part, some unique PBA-based drug delivery systems (focusing on the presenting authors' own works) will be summarized.
Sialic Acid Recognition as a New Platform for
Bio-application
2·1 Significance of sialic acid in biology
Glycoform is a term for versatile molecular forms of a glycoprotein resulting from a variable glycan structure or glycan attachment site occupancy. Glycosylations, or the alternations of the glycoforms, are dynamic and stage-specific processes that occur during numerous normal and pathological events including development, differentiation, infection, genetic disorders and cancers. [27] [28] [29] SA are the most abundant terminal residue of carbohydrate chains. The density and the distribution of SA on cell surfaces are closely related to development, differentiation and diseases. The increased expression of sialylated antigens on cells is a hallmark of cancer progression and poor prognosis in patients with lung, breast, colon, prostate, bladder, and stomach cancer. [30] [31] [32] Moreover, hypoxic regions of solid tumors have shown increased levels of sialylated antigens, 33 
2·2 Determination of sialic acid for noninvasive cytology
To analyze the cell surface SA, fluorescence labeled reagents, typically in combination with lectins capable of specifically binding with SA, are most frequently used. [35] [36] [37] However, they often involve multiple enzymatic, dye-labeling and lethal procedures, which are costly and time-consuming. Our recent work has described a noninvasive PBA-based sensor to quantify SA. 38 Of note, most sugars can complex only with the tetrahedral anionic form of boronate, because the complex with the trigonal neutral form is usually susceptible to hydrolysis. In sharp contrast, SA-PBA binding is also favored by the trigonal form, for which involvement of multiple metastable binding sites along with intramolecular stabilization via B-N or B-O interactions are suggested to play roles. 37, 39 A field effect transistor (FET)-based potentiometric biosensor was developed as a platform for noninvasive and label-free cytology. 40, 41 This technique, often termed "Bio-FETs", is based on direct transduction of surface potential change due to charged biomolecules into an electrical signal by the field effect. A PBA modified self-assembled monolayer (SAM) was immobilized on the surface of a gold electrode, which was used as an extended gate of FET ( Fig. 1(a) ). The specific binding of negatively charged SA with PBA gave rise to a shift of the electrical characteristic of Bio-FET. To demonstrate the ability of the electrode to capture SA moieties on the cell membranes, erythrocyte was first investigated, for which a decline of SA content has been implicated in diabetes mellitus. 38 The altered SA level could be assessed in a real-time manner, simply by placing the known-count living cell suspensions onto the electrode. The electrode was further applied to the assessment of malignancy or the degree of metastasis of a tissue (murine melanoma: B16-F10-Luc-G5) specimen (Fig. 1(b) ). 42 It was demonstrated that the PBA-modified electrode could differentiate the degree of tumor metastasis through perception of the cell membranes SA. These techniques may offer facile and quantitative adjunct to histological evaluation of tumor malignancy and metastatic potential during intra-or post-operative diagnoses.
2·3 Diagnostic and therapeutic strategies targeting to SA
The PBA-SA interaction stated above has also been exploited as a means to label sialylated epitopes in vitro and in vivo. 43, 44 Also, the fact that elevated sialylation is a common signature of tumor malignancy suggests a new rationale for delivering bioactive or -inactive substances specifically to the site of tumors. [43] [44] [45] [46] Crich et al. developed a gadolinium macrocyclic complex conjugated with PBA (Gd III -dota-en-pba) for use as a contrast agent for MRI (magnetic resonance imaging) in vivo imaging (Fig. 2) . 47 First, two clones of B16-F10 murine melanoma each characterized by a different phenotype expressing different levels of sialylation, namely melanogenic (B16-F10m) and nonmelanogenic (B16-F10non) cells, were tested in vitro. A solid correlation between Gd III -dota-en-pba uptake and the sialylation level was confirmed. Then, in vivo MRI experiments were carried out on mice models bearing a tumor xenograft obtained by subcutaneous injection of B16-F10 cells. Remarkably increased tumor-specific contrast in T1-weighted MR spin-echo images were obtained, thus demonstrating the feasibility of in vivo tumor targeting based on the recognition of overexpressed SA by the PBA-conjugated reporter.
The polymeric micelles self-assembled from biodegradable and biocompatible amphiphilic block copolymers represent a promising platform for the delivery of anticancer drugs, as attested by a number of such formulations currently in clinical trials. 48 These nano-sized polymer micelles, typically several tens of nanometers in size, can effectively accumulate to the sites of tumors owing to their leaky vasculature and dysfunctional lymphatic drainage, an effect called enhanced permeability and retention (EPR effect), while limited distribution is manifested in normal tissues where more tightly knitted endothelial lining prevails. 49, 50 To further improve their delivery outcome, an Equilibrium threshold voltage (VT) shifts found by adding cell suspensions to PBA-modified gold electrodes as a function of the degree of metastasis for various cell concentrations. Data sets for the 100% tumoral fraction (dashed boxes) were obtained from cultured B16-F10-Luc-G5 (no pneumocytes), whereas those for 0% were from healthy pneumocytes. Data are expressed as averages ± standard deviation (n = 6, * and ** indicate p < 0.05 and p < 0.01, respectively, versus 0% metastasis for the same cell concentrations). Reproduced with permission from Refs. 38 and 42. active targeting strategy may offer promising options. 51 Our recent study has described a polymer micelle installed with PBA as a ligand to SA (Fig. 3) . 52 The micelle was prepared through coordination between an anticancer agent, (1,2-diaminocyclohexane)platinum(II) (DACHPt), and the carboxylic groups of PBA end-functionalized poly(ethylene glycol)-b-poly(L-glutamic acid)
[PBA-PEG-b-PLGA] copolymers in water. The ability of PBA-installed micelles (PBA-DACHPt/m) was evaluated in vitro as well as in vivo against orthotopic and metastatic tumor models. The PBA-DACHPt/m demonstrated the most potent antitumor efficacy with respect to tumor growth inhibition and prolonged survival when compared with non-targeted micelles, in line with the enhanced drug accumulation in the tumor. This finding may offer a general route to obtain enhanced drug delivery to the site of tumors via the specific PBA-SA interaction.
Other PBA-based Drug Delivery Systems

3·1 siRNA delivery
There is a growing interest in the development of delivery systems for small interfering RNA (siRNA) for its ability of gene silencing in a highly sequence-specific modality. 53, 54 A key challenge is the protection of siRNA from the endogenous RNase degradation while achieving a prompt release once reaching an intracellular environment. One promising approach is a formulation in the form of polyion complex (PIC) micelles that instantly form in an aqueous environment simply through electrostatic interactions between anionic siRNA and cationic polymers. 55 We prepared a PBA-functionalized PIC micelle encapsulating siRNA (Fig. 4) . 56 PBA is able to reversibly bind with ribose, the binding constant of which is quite high relative to those for other common sugars. We found that the binding between the pendent PBA and 3′end ribose at both ends of double stranded siRNA along with hydrophobic interaction contribute to stability of the complex in quasi-extracellular conditions. Meanwhile, the complex undergoes a disruption in response to adenosine triphosphate (ATP) at a range comparable to its intracellular concentration. Using this system, the dose-dependent silencing capability of the polo-like kinase 1 (PLK-1) gene, a well-known proto-oncogene in the human renal carcinoma cell (OSRC-2) line, was demonstrated while observing a minimized level of cytotoxicity. This synthetic carrier may have potential for intracellular environment-selective delivery of siRNA.
3·2 Insulin delivery
The development of self-regulated insulin delivery systems has been a long-standing challenge of materials science, for which exploitations of glucose oxidase and sugar-binding lectin are two prevalent strategies to install the function of glucose-sensitivity. 57 These protein-based components, however, intolerant of long-term use and storage with their denaturing and cytotoxic natures, are hardly suitable for any implantable applications and thus have not seen any clinical usage to date. We pursued a synthetic gel-based approach to address this critical issue.
A PBA-functionalized gel with properly amphiphilic backbone shows reversible and abrupt change in 
hydration.
Under optimal conditions, the hydration is accompanied by a thin-surface-localized dehydration, so-called "skin layer", 58 providing a mode to instantly control permeation of the gel-loaded insulin (Fig. 5(a) ). [59] [60] [61] [62] Our recent work has demonstrated that, with optimized structure of the gel, this self-regulated insulin-delivery could work under physiological conditions. 63 Importantly, a remarkably sharp, all-or-none type controlled release could be achieved in synchronization with the glucose-fluctuation at the range corresponding to normo-and hyperglycemia (Fig. 5(b) ). This synthetic alternative may offer a new material basis for "artificial pancreas" to treat diabetes with long-term stability and safety.
Conclusions
Some new directions of PBA-based strategies for diagnostic and therapeutic applications were reviewed. To date, glucose-sensors may be the only field where PBA chemistry has borne fruit other than some rather traditional bio-separation applications. The versatile chemistry of PBA, which can be synthetically tailored depending on the application, presents additional prospects for its use as a platform for future medical applications. 
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